Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of High Strength Fp MDPI and FS MDPI vs Flovent and Advair in Asthma
NCT02437604Phase 1Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- May 2015
- Primary completion
- Jul 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of fluticasone propionate nasal spray and salmeterol in asthma (4 arms), sponsored by Teva Pharmaceutical Industries Ltd. Primary endpoints: Area Under the Plasma Concentration-Time Curve from Time Zero to Time t and Maximum Plasma Drug Concentration. Started May 2015; status: completed.
02
Drugs
fluticasone propionate nasal spraysalmeterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02437604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02437604.